WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Global COVID-19 Data Gap Grows As Countries Stop Reporting to WHO 25/08/2023 Stefan Anderson Fewer than 20 countries worldwide still report COVID-19 hospitalization and ICU data to the World Health Organization (WHO), leaving the UN health body blind to the impact and evolution of the virus in most of the world, agency leaders said Friday. The decline in data reporting is a major setback for the WHO’s efforts to […] Continue reading -> Court Compels South Africa to Reveal Details of its COVID-19 Vaccine Contracts 17/08/2023 Kerry Cullinan The South African High Court has ordered the country’s health department to hand copies of all its COVID-19 vaccine procurement contracts, negotiations and agreements to a non-governmental organisation, Health Justice Initiative (HJI). The Pretoria High Court ruling on Thursday comes in response to a court application by HJI for access to the contracts, arguing that […] Continue reading -> WHO Europe Urges Countries to Maintain COVID-19 Surveillance as Cases Increase 16/08/2023 Kerry Cullinan Dr Hans Kluge, regional director of the World Health Organization (WHO) in Europe, has warned member countries to maintain their COVID-19 infrastructure and genomic surveillance amid a “gradual increase in cases, including hospitalizations, in some European countries”. “COVID has not gone away. While its impact currently isn’t as severe as earlier, millions, especially the most […] Continue reading -> WHO Issues New COVID-19 Recommendations 09/08/2023 Kerry Cullinan The World Health Organization (WHO) has issued new standing recommendations for COVID-19 for member states, now that the virus outbreak is no longer classified as a pandemic. The recommendations are seven-fold, WHO Director-General Dr Tedros Adhanom Ghebreysus told a media briefing on Wednesday. “First, all countries should update their national COVID-19 programmes using the WHO […] Continue reading -> Moderna’s COVID-19 Vaccine Safest for Older People 02/08/2023 Megha Kaveri Older adults vaccinated with Moderna’s COVID-19 vaccine were 15% less likely to be infected with COVID-19 than those vaccinated with Pfizer-BioNTech’s, according to a peer-reviewed study, published in JAMA Network on Wednesday. The study was based on observational data from 6.3 million adults, almost 60% women and 86.5% White, with an average age of 76 […] Continue reading -> The Cost of a Single COVID-Infected Health Worker 27/07/2023 Kerry Cullinan A single healthcare worker infected with COVID-19 cost the Kenyan economy over $33,000 – around 18 times the country’s per capita GDP. This is according to a new report on the economic cost of COVID-19 infections among healthcare workers in Eswatini, Colombia, Kenya and South Africa (the provinces of KwaZulu-Natal and Western Cape) during the […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global COVID-19 Data Gap Grows As Countries Stop Reporting to WHO 25/08/2023 Stefan Anderson Fewer than 20 countries worldwide still report COVID-19 hospitalization and ICU data to the World Health Organization (WHO), leaving the UN health body blind to the impact and evolution of the virus in most of the world, agency leaders said Friday. The decline in data reporting is a major setback for the WHO’s efforts to […] Continue reading -> Court Compels South Africa to Reveal Details of its COVID-19 Vaccine Contracts 17/08/2023 Kerry Cullinan The South African High Court has ordered the country’s health department to hand copies of all its COVID-19 vaccine procurement contracts, negotiations and agreements to a non-governmental organisation, Health Justice Initiative (HJI). The Pretoria High Court ruling on Thursday comes in response to a court application by HJI for access to the contracts, arguing that […] Continue reading -> WHO Europe Urges Countries to Maintain COVID-19 Surveillance as Cases Increase 16/08/2023 Kerry Cullinan Dr Hans Kluge, regional director of the World Health Organization (WHO) in Europe, has warned member countries to maintain their COVID-19 infrastructure and genomic surveillance amid a “gradual increase in cases, including hospitalizations, in some European countries”. “COVID has not gone away. While its impact currently isn’t as severe as earlier, millions, especially the most […] Continue reading -> WHO Issues New COVID-19 Recommendations 09/08/2023 Kerry Cullinan The World Health Organization (WHO) has issued new standing recommendations for COVID-19 for member states, now that the virus outbreak is no longer classified as a pandemic. The recommendations are seven-fold, WHO Director-General Dr Tedros Adhanom Ghebreysus told a media briefing on Wednesday. “First, all countries should update their national COVID-19 programmes using the WHO […] Continue reading -> Moderna’s COVID-19 Vaccine Safest for Older People 02/08/2023 Megha Kaveri Older adults vaccinated with Moderna’s COVID-19 vaccine were 15% less likely to be infected with COVID-19 than those vaccinated with Pfizer-BioNTech’s, according to a peer-reviewed study, published in JAMA Network on Wednesday. The study was based on observational data from 6.3 million adults, almost 60% women and 86.5% White, with an average age of 76 […] Continue reading -> The Cost of a Single COVID-Infected Health Worker 27/07/2023 Kerry Cullinan A single healthcare worker infected with COVID-19 cost the Kenyan economy over $33,000 – around 18 times the country’s per capita GDP. This is according to a new report on the economic cost of COVID-19 infections among healthcare workers in Eswatini, Colombia, Kenya and South Africa (the provinces of KwaZulu-Natal and Western Cape) during the […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Court Compels South Africa to Reveal Details of its COVID-19 Vaccine Contracts 17/08/2023 Kerry Cullinan The South African High Court has ordered the country’s health department to hand copies of all its COVID-19 vaccine procurement contracts, negotiations and agreements to a non-governmental organisation, Health Justice Initiative (HJI). The Pretoria High Court ruling on Thursday comes in response to a court application by HJI for access to the contracts, arguing that […] Continue reading -> WHO Europe Urges Countries to Maintain COVID-19 Surveillance as Cases Increase 16/08/2023 Kerry Cullinan Dr Hans Kluge, regional director of the World Health Organization (WHO) in Europe, has warned member countries to maintain their COVID-19 infrastructure and genomic surveillance amid a “gradual increase in cases, including hospitalizations, in some European countries”. “COVID has not gone away. While its impact currently isn’t as severe as earlier, millions, especially the most […] Continue reading -> WHO Issues New COVID-19 Recommendations 09/08/2023 Kerry Cullinan The World Health Organization (WHO) has issued new standing recommendations for COVID-19 for member states, now that the virus outbreak is no longer classified as a pandemic. The recommendations are seven-fold, WHO Director-General Dr Tedros Adhanom Ghebreysus told a media briefing on Wednesday. “First, all countries should update their national COVID-19 programmes using the WHO […] Continue reading -> Moderna’s COVID-19 Vaccine Safest for Older People 02/08/2023 Megha Kaveri Older adults vaccinated with Moderna’s COVID-19 vaccine were 15% less likely to be infected with COVID-19 than those vaccinated with Pfizer-BioNTech’s, according to a peer-reviewed study, published in JAMA Network on Wednesday. The study was based on observational data from 6.3 million adults, almost 60% women and 86.5% White, with an average age of 76 […] Continue reading -> The Cost of a Single COVID-Infected Health Worker 27/07/2023 Kerry Cullinan A single healthcare worker infected with COVID-19 cost the Kenyan economy over $33,000 – around 18 times the country’s per capita GDP. This is according to a new report on the economic cost of COVID-19 infections among healthcare workers in Eswatini, Colombia, Kenya and South Africa (the provinces of KwaZulu-Natal and Western Cape) during the […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Europe Urges Countries to Maintain COVID-19 Surveillance as Cases Increase 16/08/2023 Kerry Cullinan Dr Hans Kluge, regional director of the World Health Organization (WHO) in Europe, has warned member countries to maintain their COVID-19 infrastructure and genomic surveillance amid a “gradual increase in cases, including hospitalizations, in some European countries”. “COVID has not gone away. While its impact currently isn’t as severe as earlier, millions, especially the most […] Continue reading -> WHO Issues New COVID-19 Recommendations 09/08/2023 Kerry Cullinan The World Health Organization (WHO) has issued new standing recommendations for COVID-19 for member states, now that the virus outbreak is no longer classified as a pandemic. The recommendations are seven-fold, WHO Director-General Dr Tedros Adhanom Ghebreysus told a media briefing on Wednesday. “First, all countries should update their national COVID-19 programmes using the WHO […] Continue reading -> Moderna’s COVID-19 Vaccine Safest for Older People 02/08/2023 Megha Kaveri Older adults vaccinated with Moderna’s COVID-19 vaccine were 15% less likely to be infected with COVID-19 than those vaccinated with Pfizer-BioNTech’s, according to a peer-reviewed study, published in JAMA Network on Wednesday. The study was based on observational data from 6.3 million adults, almost 60% women and 86.5% White, with an average age of 76 […] Continue reading -> The Cost of a Single COVID-Infected Health Worker 27/07/2023 Kerry Cullinan A single healthcare worker infected with COVID-19 cost the Kenyan economy over $33,000 – around 18 times the country’s per capita GDP. This is according to a new report on the economic cost of COVID-19 infections among healthcare workers in Eswatini, Colombia, Kenya and South Africa (the provinces of KwaZulu-Natal and Western Cape) during the […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Issues New COVID-19 Recommendations 09/08/2023 Kerry Cullinan The World Health Organization (WHO) has issued new standing recommendations for COVID-19 for member states, now that the virus outbreak is no longer classified as a pandemic. The recommendations are seven-fold, WHO Director-General Dr Tedros Adhanom Ghebreysus told a media briefing on Wednesday. “First, all countries should update their national COVID-19 programmes using the WHO […] Continue reading -> Moderna’s COVID-19 Vaccine Safest for Older People 02/08/2023 Megha Kaveri Older adults vaccinated with Moderna’s COVID-19 vaccine were 15% less likely to be infected with COVID-19 than those vaccinated with Pfizer-BioNTech’s, according to a peer-reviewed study, published in JAMA Network on Wednesday. The study was based on observational data from 6.3 million adults, almost 60% women and 86.5% White, with an average age of 76 […] Continue reading -> The Cost of a Single COVID-Infected Health Worker 27/07/2023 Kerry Cullinan A single healthcare worker infected with COVID-19 cost the Kenyan economy over $33,000 – around 18 times the country’s per capita GDP. This is according to a new report on the economic cost of COVID-19 infections among healthcare workers in Eswatini, Colombia, Kenya and South Africa (the provinces of KwaZulu-Natal and Western Cape) during the […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna’s COVID-19 Vaccine Safest for Older People 02/08/2023 Megha Kaveri Older adults vaccinated with Moderna’s COVID-19 vaccine were 15% less likely to be infected with COVID-19 than those vaccinated with Pfizer-BioNTech’s, according to a peer-reviewed study, published in JAMA Network on Wednesday. The study was based on observational data from 6.3 million adults, almost 60% women and 86.5% White, with an average age of 76 […] Continue reading -> The Cost of a Single COVID-Infected Health Worker 27/07/2023 Kerry Cullinan A single healthcare worker infected with COVID-19 cost the Kenyan economy over $33,000 – around 18 times the country’s per capita GDP. This is according to a new report on the economic cost of COVID-19 infections among healthcare workers in Eswatini, Colombia, Kenya and South Africa (the provinces of KwaZulu-Natal and Western Cape) during the […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Cost of a Single COVID-Infected Health Worker 27/07/2023 Kerry Cullinan A single healthcare worker infected with COVID-19 cost the Kenyan economy over $33,000 – around 18 times the country’s per capita GDP. This is according to a new report on the economic cost of COVID-19 infections among healthcare workers in Eswatini, Colombia, Kenya and South Africa (the provinces of KwaZulu-Natal and Western Cape) during the […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy